Clinical Trial Update: Phase 2a Study for PK/PD of nC-001 [Phase 2]

View source ↗

Summary

A Phase 2a PK/PD study of nC-001 for chronic hyponatremia is planned, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• nC-001

Snippet

Sponsor: nephCentric | Conditions: CHRONIC HYPONATREMIA | Phase 2 | Status: NOT_YET_RECRUITING